ID

35067

Descripción

Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02491697

Link

https://clinicaltrials.gov/show/NCT02491697

Palabras clave

Versiones (1)
  1. 13/2/19 13/2/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

13 de febrero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT02491697

Inglés

Eligibility Breast Cancer NCT02491697

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed with advanced breast cancer.
Descripción

Advanced breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3495917
eastern cooperative oncology group (ecog) performance status was 0 - 2.
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
hemoglobin≥10.0g/dl, neutrophil count≥1.5×10^9/l, platelet count≥75×10^9/l; total bilirubin(tbil)≤1.5×uln; alkaline phosphatase(akp), aspartate aminotransferase(ast),alt≤2.5×uln(without metastasis of the liver), akp,ast,alt≤5×uln(with metastasis of the liver); bun≤1.5×uln, cr≤1.5×uln.
Descripción

Hemoglobin measurement | Neutrophil count | Platelet Count measurement | Serum total bilirubin measurement | Alkaline phosphatase measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver Absent | Secondary malignant neoplasm of liver | Blood urea nitrogen measurement | Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0200633
UMLS CUI [3]
C0032181
UMLS CUI [4]
C1278039
UMLS CUI [5]
C0201850
UMLS CUI [6]
C0201899
UMLS CUI [7]
C0201836
UMLS CUI [8,1]
C0494165
UMLS CUI [8,2]
C0332197
UMLS CUI [9]
C0494165
UMLS CUI [10]
C0005845
UMLS CUI [11]
C0201976
patient received 1-2 kinds of cytotoxic chemotherapy previously.
Descripción

Cytotoxic Chemotherapy Kind Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C0332307
UMLS CUI [1,3]
C1265611
patient never received capecitabine or other oral fluorouracil.
Descripción

Capecitabine Absent | Fluorouracil Oral Product Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0671970
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C3215189
UMLS CUI [2,2]
C0332197
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who are suffering from serious organ dysfunction.
Descripción

Organ dysfunction Serious

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0349410
UMLS CUI [1,2]
C0205404
hiv positive or other immunodeficiency disease.
Descripción

HIV Seropositivity | Immunodeficiency

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0021051
patients who had used long time or are using immunosuppressant drugs.
Descripción

Immunosuppressive Agents

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021081
patients who had active infection.
Descripción

Communicable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
patients who were allergic to fluorouracil.
Descripción

Fluorouracil allergy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0570698
pregnant or lactating women.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of other malignancies.
Descripción

Cancer Other

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707251
other situations that the researchers considered unsuitable for this study.
Descripción

Social situation Study Subject Participation Status Inappropriate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0748872
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C1548788
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT02491697

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Advanced breast cancer
Item
histologically confirmed with advanced breast cancer.
boolean
C3495917 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status was 0 - 2.
boolean
C1520224 (UMLS CUI [1])
Hemoglobin measurement | Neutrophil count | Platelet Count measurement | Serum total bilirubin measurement | Alkaline phosphatase measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver Absent | Secondary malignant neoplasm of liver | Blood urea nitrogen measurement | Creatinine measurement, serum
Item
hemoglobin≥10.0g/dl, neutrophil count≥1.5×10^9/l, platelet count≥75×10^9/l; total bilirubin(tbil)≤1.5×uln; alkaline phosphatase(akp), aspartate aminotransferase(ast),alt≤2.5×uln(without metastasis of the liver), akp,ast,alt≤5×uln(with metastasis of the liver); bun≤1.5×uln, cr≤1.5×uln.
boolean
C0518015 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C1278039 (UMLS CUI [4])
C0201850 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
C0494165 (UMLS CUI [8,1])
C0332197 (UMLS CUI [8,2])
C0494165 (UMLS CUI [9])
C0005845 (UMLS CUI [10])
C0201976 (UMLS CUI [11])
Cytotoxic Chemotherapy Kind Quantity
Item
patient received 1-2 kinds of cytotoxic chemotherapy previously.
boolean
C0677881 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Capecitabine Absent | Fluorouracil Oral Product Absent
Item
patient never received capecitabine or other oral fluorouracil.
boolean
C0671970 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C3215189 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Organ dysfunction Serious
Item
patients who are suffering from serious organ dysfunction.
boolean
C0349410 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
HIV Seropositivity | Immunodeficiency
Item
hiv positive or other immunodeficiency disease.
boolean
C0019699 (UMLS CUI [1])
C0021051 (UMLS CUI [2])
Immunosuppressive Agents
Item
patients who had used long time or are using immunosuppressant drugs.
boolean
C0021081 (UMLS CUI [1])
Communicable Disease
Item
patients who had active infection.
boolean
C0009450 (UMLS CUI [1])
Fluorouracil allergy
Item
patients who were allergic to fluorouracil.
boolean
C0570698 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Cancer Other
Item
history of other malignancies.
boolean
C1707251 (UMLS CUI [1])
Social situation Study Subject Participation Status Inappropriate
Item
other situations that the researchers considered unsuitable for this study.
boolean
C0748872 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial